Kidney Cancer

Study: Older Age Should Not Preclude Partial Nephrectomy

Study: Older Age Should Not Preclude Partial Nephrectomy

By

Partial and radical nephrectomy were associated with similar cancer-specific and overall survival in elderly patients.

CB-839 Drug Promising for Clear Cell, Papillary Renal Cell Cancer

CB-839 Drug Promising for Clear Cell, Papillary Renal Cell Cancer

In the 15 patients in the study, the dual treatment controlled tumors in 93% of the patients, who had either clear cell or papillary renal cell cancer.

Age at Cancer Diagnosis Predicts Cardiac Risk

Age at Cancer Diagnosis Predicts Cardiac Risk

Cancer patients diagnosed in their teens had a more than 4-fold higher risk of death from cardiac disease than patients who didn't have cancer.

Robotic Partial Nephrectomy Offers Better Morbidity Than Laparoscopic

Robotic Partial Nephrectomy Offers Better Morbidity Than Laparoscopic

Robotic partial nephrectomy confers a superior morbidity profile compared to laparoscopic partial nephrectomy.

Renal-Cell Cancer Disease-Free Survival Up With Sunitinib

Renal-Cell Cancer Disease-Free Survival Up With Sunitinib

Among patients with clear-cell renal-cell carcinoma at high risk for tumor recurrence, the duration of disease-free survival was significantly longer in the sunitinib group.

Obesity Ups Risk for Secondary Primary Cancers in Men

Obesity Ups Risk for Secondary Primary Cancers in Men

Prediagnosis obesity is a risk factor for overall and individual secondary primary cancers.

Cabozantinib Superior as Front-Line Therapy for Advanced RCC

Cabozantinib Superior as Front-Line Therapy for Advanced RCC

By

Use of the drug is associated with significantly longer progression-free survival compared with suninitib in treatment-naïve patients.

TKI Dose Escalation After mRCC Progression Beneficial

TKI Dose Escalation After mRCC Progression Beneficial

By

In a small study, researchers observed a decrease in tumor burden and extended duration of therapy.

Partial Nephrectomy Use Increasing

Partial Nephrectomy Use Increasing

By

Study of US veterans reveals, however, that the procedure is being used less in subgroups who might benefit the most.

Immunotherapy Increasingly Used in Cancer Care

Immunotherapy Increasingly Used in Cancer Care

Immunotherapy treatments for patients with bladder cancer, head and neck cancer, Hodgkin's lymphoma, and kidney cancer, is useful against malignancy, according to Cancer Progress Report.

Data Support Biopsy Before Renal Cryo

Data Support Biopsy Before Renal Cryo

By

The recurrence group had significantly larger tumors than the no-recurrence group.

Higher Complication Rate Found With Open Partial Nephrectomy

Higher Complication Rate Found With Open Partial Nephrectomy

By

Open partial nephrectomy had a significantly higher rate of complications.

High BMI Predicts Improved RCC Patient Survival

High BMI Predicts Improved RCC Patient Survival

By

Paradoxical association could be related to an altered fatty acid pathway.

Slimmer People Have Lower Risks of Kidney, Other Cancers

Slimmer People Have Lower Risks of Kidney, Other Cancers

International committee finds slimmer individuals less likely to develop variety of malignancies.

Robotic, Open PN Similarly Effective for Endophytic Kidney Tumors

Robotic, Open PN Similarly Effective for Endophytic Kidney Tumors

By

Robotic surgery may offer some benefits, such as shorter hospital stay and less blood loss.

Kidney Cancer Risk Linked to Metalworking Fluids

Kidney Cancer Risk Linked to Metalworking Fluids

By

Mean exposure of 18.80 mg/m3 per year was associated with a significant 11% increased risk among white men.

Active Surveillance Possible Before Treatment in mRCC

Active Surveillance Possible Before Treatment in mRCC

Some metastatic RCC patients may safely undergo surveillance prior to starting systematic therapy.

Metabolic Factors Linked to RCC Treatment Resistance

Metabolic Factors Linked to RCC Treatment Resistance

Research results provide potential new targets for combination therapy regimens.

Aspirin Does Not Hike Kidney Surgery Bleeding Complications

Aspirin Does Not Hike Kidney Surgery Bleeding Complications

By

Study finds no increased risk of overall complications in patients undergoing robotic partial nephrectomy.

Chest X-Rays May Miss Pulmonary Metastases in T1a RCC Patients

Chest X-Rays May Miss Pulmonary Metastases in T1a RCC Patients

Findings in patients treated for T1a renal cell carcinoma followed with X-ray surveillance.

Smaller Renal Tumors Predict Longer Surgical Wait Times

Smaller Renal Tumors Predict Longer Surgical Wait Times

By

Patients whose surgical wait time was 3 months or more versus less than 3 months had 10-fold increased odds of having a smaller tumor.

Disseminated Cancer Increases Nephrectomy Complication Rate

Disseminated Cancer Increases Nephrectomy Complication Rate

By

Disseminated cancer at the time of radical nephrectomy is associated with 2-fold increased odds of major perioperative complications.

Laparoscopic Nephrectomy May Be Performed as Outpatient Surgery

Laparoscopic Nephrectomy May Be Performed as Outpatient Surgery

Most patients discharged home within first 6 hours after surgery; none readmitted.

Cabozantinib Shows Superiority in Treating Advanced mRCC

Cabozantinib Shows Superiority in Treating Advanced mRCC

By

The drug significantly improves overall and progression-free survival compared with everolimus, researchers report.

Early Tumor Shrinkage Predicts mRCC Treatment Outcomes

Early Tumor Shrinkage Predicts mRCC Treatment Outcomes

By

The optimal tumor shrinkage threshold for predicting overall and progression-free survival is 10%, researchers concluded.

Achieving 4 Lifestyle Standards May Reduce Cancer Mortality

Achieving 4 Lifestyle Standards May Reduce Cancer Mortality

Four key lifestyle factors include weight, exercise, no smoking, and limiting alcohol.

Leisure Activity Linked With Lower Risk of Several Cancers

Leisure Activity Linked With Lower Risk of Several Cancers

Findings for self-reported leisure-time physical activity of moderate to vigorous intensity.

Higher Cancer Risk in Dialysis Patients Confirmed

Higher Cancer Risk in Dialysis Patients Confirmed

By

The risk is most elevated among individuals aged 44 years or younger.

Survival Advantage Confirmed for Nephrectomy in mRCC

Survival Advantage Confirmed for Nephrectomy in mRCC

By

About 25% of patients who present with metastatic renal cancer will undergo nephrectomy after diagnosis.

Cytoreductive Nephrectomy Benefits Select mRCC Patients Taking TT

Cytoreductive Nephrectomy Benefits Select mRCC Patients Taking TT

By

Among patients treated with targeted therapy, overall survival was 17.1 months for CN recipients vs 7.7 months for those without CN.

Sign Up for Free e-newsletters